On Mar 2, 2022 Rondo Therapeutics closed a Series A round and raised $67,000,000 from Canaan Partners, Johnson & Johnson Innovation – JJDC, Novo Holdings, Red Tree Venture Capital, SV Health Investors, featuring lead investors Canaan Partners, Red Tree Venture Capital.
About the company: Rondo Therapeutics is located at United States, North America.
“”
Company website: http://www.rondotx.com